| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.038 | 0.8 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.035 | 0.8 |